Kidney transplantation from living donors is an established treatment for end-stage renal disease: it increases life expectancy, improves quality of life and is less costly than dialysis. In Canada, the growth of solid-organ transplantation over the past decade has primarily been attributable to
No takes yet. Share an insight, caveat, or question.
Scott Klarenbach (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: